Ikonisys S.A. (ALIKO.PA)

EUR 1.47

(8.09%)

EBITDA Summary of Ikonisys S.A.

  • Ikonisys S.A.'s latest annual EBITDA in 2023 was -2.34 Million EUR , down -73.68% from previous year.
  • Ikonisys S.A.'s latest quarterly EBITDA in 2024 Q2 was -1.33 Million EUR , down 0.0% from previous quarter.
  • Ikonisys S.A. reported an annual EBITDA of -1.35 Million EUR in 2022, down -93.97% from previous year.
  • Ikonisys S.A. reported an annual EBITDA of -483.65 Thousand EUR in 2021, down -519.63% from previous year.
  • Ikonisys S.A. reported a quarterly EBITDA of -426.76 Thousand EUR for 2023 Q2, up 19.18% from previous quarter.
  • Ikonisys S.A. reported a quarterly EBITDA of N/A for 2023 FY, up 16.84% from previous quarter.

Annual EBITDA Chart of Ikonisys S.A. (2023 - 2019)

Historical Annual EBITDA of Ikonisys S.A. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 -2.34 Million EUR -73.68%
2022 -1.35 Million EUR -93.97%
2021 -483.65 Thousand EUR -519.63%
2020 - EUR 37.54%
2019 -180.04 Thousand EUR 0.0%

Peer EBITDA Comparison of Ikonisys S.A.

Name EBITDA EBITDA Difference
Affluent Medical SA -13.34 Million EUR 82.406%
Bluelinea Société Anonyme -323.98 EUR -724489.789%
Carmat SA -50.45 Million EUR 95.347%
Diagnostic Medical Systems S.A. -7.05 Million EUR 66.735%
Euromedis Groupe -4.43 Million EUR 47.07%
Eurobio Scientific Société anonyme 18.98 Million EUR 112.365%
Implanet S.A. -5.07 Million EUR 53.762%
Median Technologies SA -19.58 Million EUR 88.014%
SpineGuard SA -3.49 Million EUR 32.867%
Theraclion SA -4.48 Million EUR 47.684%
Euroapi S.A. -155.39 Million EUR 98.489%
Guerbet SA 98.83 Million EUR 102.375%
Ion Beam Applications SA 12.53 Million EUR 118.735%
Koninklijke Philips N.V. 1.04 Billion EUR 100.226%
Sequana Medical NV -29.13 Million EUR 91.943%